![Zhi Ang Wu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhi Ang Wu
Direktor/Vorstandsmitglied bei LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.
Aktive Positionen von Zhi Ang Wu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Direktor/Vorstandsmitglied | 23.04.2020 | - |
Independent Dir/Board Member | 23.04.2020 | - | |
SHANDONG LUOXIN PHARMACY GROUP CO LTD | Direktor/Vorstandsmitglied | 23.04.2020 | - |
Independent Dir/Board Member | 23.04.2020 | - |
Karriereverlauf von Zhi Ang Wu
Ehemalige bekannte Positionen von Zhi Ang Wu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - |
Statistik
International
China | 4 |
Operativ
Director/Board Member | 3 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. | Health Technology |
LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
![]() Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on May 05, 1998 and is headquartered in Linyi, China. | Health Technology |
- Börse
- Insiders
- Zhi Ang Wu
- Erfahrung